Exacerbation Study

Clinical trial NCT00845728 · COMPLETED

Trial details

NCT number: NCT00845728
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2009-03-01
Primary completion: 2012-07-01
Enrollment: 3439

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.